New Clinical Trials Available
Medical researchers continue to discover new sight-saving treatments for retinal diseases that once robbed patients of their vision. At Texas Retina Associates, we are currently participating in more than 20 clinical trials
read more
February is AMD/Low Vision Awareness Month
By Ivan G. Castillo, MD February is national age-related macular degeneration (AMD) and low vision awareness month. Low vision is a visual impairment that cannot be corrected by standard eyeglasses, contact lenses, medication
read more
New Clinical Trials Offer Patients Access to Promising New Retina Treatments
At Texas Retina Associates, we remain committed to safely providing our patients with compassionate and personalized retina care, including access to breakthrough, sight-saving treatments through clinical trials. In fact, our physicians have
read more Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema
Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye
read more
Ashkan Abbey, MD, Publishes Article Summarizing Highlights from American Academy of Ophthalmology Retina 2019 Subspecialty Day
Texas Retina Associates’ Ashkan Abbey, MD, recently published an article in the current issue of Retina Specialist that summarized the findings of five compelling clinical trial presentations from the American Academy of
read more
David Callanan, MD, Presented Uveitis Clinical Trial Results at American Society of Retina Specialists 2019 Annual Meeting
Texas Retina Associates’ David Callanan, MD, presented the results of a clinical trial on a promising new treatment for chronic posterior segment uveitis at the American Society of Retina Specialists (ASRS) 2019
read more
Clinical Trials Help Uncover New Sight-Saving Treatment Options
At Texas Retina Associates, our physicians are committed to continually improving care for our patients, and a big part of that involves conducting ongoing research of potential new sight-saving retina treatments. Clinical
read more